Biomarker ID | 1509 |
PMID | 25151013 |
Year | 2015 |
Biomarker | Base model (Age and total PSA) |
Biomarker Basis | Concentration Based (ng/mL) |
Biomolecule | Protein |
Source | Plasma |
Subjects | Humans |
Regulation | NA |
Odds Ratio/Hazard Ratio/Relative Risk | NA |
Effect on Pathways | Pathways include (hK2): Galactose metabolism, Fructose and mannose metabolism, Hexose transport, Carbohydrate metabolism, SLC-mediated transmembrane transport |
Experiment | Prostate Cancer Vs No Prostate Cancer |
Type of Biomarker | Diagnostic |
Cohort | 531 men with PSA levels between 3 and 15 ng/ml undergoing first-time prostate biopsy were chosen. 271 had Prostate cancer and 231 had Benign Biopsy |
Senstivity | NA |
Specificity | NA |
AUC | 54.5(95% CI: 49.6–59.4) |
Accuracy | NA |
Level Of Significance | NA |
Method Used | NA |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Not validated on independent patient dataset |
Technical Name | NA |